Microbot Medical Inc. MBOT
1.10 USD -0.01 (-0.90%)
At closeNov 9, 2026, 4:41 PM EST
1.10 0.00 0.00%
After hours · Nov 9, 4:41 PM ET
1.10 Day range 1.15
0.94 52-week range 2.85
- YTD
- -45.00%
- 1 year
- -46.34%
News
globenewswire.com Microbot Medical® Strengthens IP Portfolio as it Continues to Establish Infrastructure to Support Future Commercialization Expansion HINGHAM, Mass., Nov. 05, 2026 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, today announced that the…
benzinga.com Microbot Medical Receives Order From ELMNT IR For 12-Month Supply Of Liberty Devices Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, today announced that ELMNT IR, a multisite outpatient interventional radiology…
benzinga.com Citizens Initiates Coverage On Microbot Medical with Market Outperform Rating, Announces Price Target of $2.5 Citizens analyst Daniel Stauder initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Market Outperform rating and announces Price Target of $2.5.- benzinga.com HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
benzinga.com Microbot Medical Receives Several New Patent Approvals Across US, Japan, China And Canada, Further Strengthening Its Global IP Portfolio The Company now holds 44 issued patents and 49 pending patents globally. Commercialization continues to advance across both U.S. and international markets.HINGHAM, Mass., Oct. 20, 2026 (GLOBE…
benzinga.com Microbot Medical Inks Three-Year Distribution Deal With Medtechnica To Advertise, Sell LIBERTY System In Israel Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has signed a three-year exclusive commercial distribution…
benzinga.com B. Riley Securities Reiterates Buy on Microbot Medical, Lowers Price Target to $4 B. Riley Securities analyst Anderson Schock reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and lowers the price target from $5 to $4.- benzinga.com Microbot Medical Q2 EPS $(0.08), Inline, Sales $241.000K Miss $340.000K Estimate Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.08) per share which met the analyst consensus estimate. This is a 20 percent increase over losses of $(0.10) per share from the same…
benzinga.com Microbot Medical Reports 100% Growth In Revenue, New Clients In Q2 Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, is reporting greater than 100% growth in revenue and new customers for the…
benzinga.com Microbot Medical Signs Letter With Manufacturer Sanmina To Produce Its LIBERTY Single-Use, Remotely Operated Endovascular Robotic System As momentum continues to rise in the U.S., reflected in increased accounts and usage across several states, and with the momentum building in the international markets as seen with the recent…- benzinga.com Microbot Medical Inks Agreement With Lovell Government Services To Serve Federal Healthcare Systems Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, has entered into an agreement with Lovell® Government Services to serve federal…
- benzinga.com LUCID CAPITAL MARKETS Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $4 LUCID CAPITAL MARKETS analyst Alex Nowark initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $4.
benzinga.com Microbot Medical Receives Israel's Marketing Clearance For Its LIBERTY System Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that it has achieved a significant regulatory milestone as Israel…
benzinga.com Watching Microbot Medical; Shares See Volume To The Downside; White Diamond Research Issues Report On Co https://whitediamondresearch.com/research/we-interviewed-some-of-the-first-surgeons-to-use-microbot-medicals-liberty-endovascular-robotic-system-and-its-clear-that-it-will-be-a-commercial-failure-1-pr…- benzinga.com Microbot Medical Announces LIBERTY System Gains Clinical Validation And Early Commercial Adoption As Global Expansion Accelerates Commercial adoption of the LIBERTY System by sites that participated in the clinical trial serves as a strong validation of the value it brings to everyday practiceThe Company will attend the Annual…
- benzinga.com HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
- benzinga.com Microbot Medical Completes Limited Market Release Of Its LIBERTY Endovascular Robotic System, With Commencement Of Full Market Release In The U.S. Proceeding As Planned To date, LIBERTY has been adopted by multiple healthcare systems with dozens of hospitals in their networks, including globally recognized hospitals such as Emory Healthcare and Tampa General…
- benzinga.com Microbot Medical Q4 EPS $(0.04) Beats $(0.06) Estimate Microbot Medical (NASDAQ:MBOT) reported quarterly losses of $(0.04) per share which beat the analyst consensus estimate of $(0.06) by 33.33 percent. This is a 78.95 percent increase over losses of…
- benzinga.com Emory Healthcare Announces Successful Use Of Microbot Medical's Liberty System In Robotic Peripheral Endovascular Procedures Emory interventional radiologists have now demonstrated successful use of the LIBERTY System on benign prostatic hyperplasia (BPH, commonly known as enlarged prostate), as well as liver cancer.
- benzinga.com Microbot Medical Commends American Medical Association's Expanding Efforts To Protect Health Care Professionals From Ionizing Radiation Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, commends the American Medical Association's (AMA) expanding efforts to protect…
benzinga.com Tampa General Hospital Adopts Small-Cap Microbot Medical's Robotic System Microbot Medical stock jumps after Tampa General adopts its FDA-cleared LIBERTY robotic system ahead of April 2026 launch.- benzinga.com Microbot Medical Highlights LIBERTY Endovascular Robotic System At ISET Conference International Symposium on Endovascular Therapy (ISET) Convened Key Opinion Leaders to Discuss Advancements and Future Role of Endovascular RoboticsLIBERTY® Continues to Gain Commercial Traction and…
benzinga.com Looking Into Microbot Medical Inc's Recent Short Interest 
benzinga.com This Microbot Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 2 Initiations For Tuesday - benzinga.com B. Riley Securities Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5 B. Riley Securities analyst Anderson Schock initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $5.
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session 
benzinga.com Why Credo Technology Group Shares Are Trading Higher By Over 17%; Here Are 20 Stocks Moving Premarket - benzinga.com Microbot Medical Says It Enters 2026 With Market Momentum Following FDA 510(k) Clearance Of LIBERTY, Single‑Use Endovascular Robotic System Limited Market Release (LMR) of the LIBERTY® System is on ScheduleBuilding on Positive Customer Feedback and Growing Market Enthusiasm, the Company Prepares for Full Market Release (FMR) in…
- benzinga.com Roth Capital Initiates Coverage On Microbot Medical with Buy Rating, Announces Price Target of $5.5 Roth Capital analyst Kyle Bauser initiates coverage on Microbot Medical (NASDAQ:MBOT) with a Buy rating and announces Price Target of $5.5.
- benzinga.com HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
- benzinga.com Microbot Medical Says Emory University Hospital Adopts LIBERTY For Patient Care; Microbot Collaborates With Emory To Establish Endovascular Robotics Program In Interventional Radiology Microbot Medical Inc. (NASDAQ:MBOT), developer and distributor of the innovative LIBERTY Endovascular Robotic System, announced that Emory University Hospital, a nationally recognized academic…
- benzinga.com Microbot Medical Announces Commercial Availability Of LIBERTY Robotic System In U.S. Microbot Medical Inc. (Nasdaq: MBOT), developer and distributor of the innovative LIBERTY® Endovascular Robotic System, announced that its LIBERTY® System, the first FDA cleared single-use, remotely…
- benzinga.com Microbot Medical Announces It Will Exhibit Its Liberty Endovascular Robotic System At Symposium On Clinical Interventional Oncology In Miami, Fl, October 17-19, 2025, Marking First Commercial Exhibition Of The System Following Its FDA 510(K) Clearance In September 2025 Microbot Medical Inc. (NASDAQ:MBOT), developer and distributer of the innovative LIBERTY® Endovascular Robotic System, today announced that it will be exhibiting the LIBERTY® System at the upcoming…
- benzinga.com HC Wainwright & Co. Reiterates Buy on Microbot Medical, Maintains $12 Price Target HC Wainwright & Co. analyst Raghuram Selvaraju reiterates Microbot Medical (NASDAQ:MBOT) with a Buy and maintains $12 price target.
benzinga.com Aon To Rally Around 19%? Here Are 10 Top Analyst Forecasts For Thursday - benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
benzinga.com Why Robinhood Shares Are Trading Higher By Over 7%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session 
benzinga.com Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session
benzinga.com Why Smart Share Global Shares Are Trading Higher By 44%; Here Are 20 Stocks Moving Premarket - benzinga.com Why Core & Main Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
- benzinga.com Why HealthEquity Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
- benzinga.com Why Science Applications International Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Monday's Mid-Day Session
- benzinga.com Why Fisker Shares Are Trading Higher By Over 20%? Here Are Other Stocks Moving In Friday's Mid-Day Session Shares of Fisker Inc. (NYSE: FSR) rose sharply during Friday’s session after the company provided a December 2023 business update.
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Gold Moves Lower; US Crude Stocks Decline Last Week U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining more than 100 points on Thursday. The Dow traded up 0.27% to 37,758.26 while the NASDAQ rose 0.17% to 15,124.90.…
- benzinga.com Why DouYu International Shares Are Trading Higher By 14%? Here Are Other Stocks Moving In Thursday's Mid-Day Session Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share repurchase program.